HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of Cydonia oblonga Miller extracts on blood hemostasis, coagulation and fibrinolysis in mice, and experimental thrombosis in rats.

AbstractINTRODUCTION:
Cydonia oblonga Miller (COM) is traditionally used in Uyghur medicine for the prevention of cardiovascular disease. The present study is designed to explore the effects of COM extracts on models and markers of thrombosis and related biomarkers.
MATERIALS AND METHODS:
20, 40, 80 mg/kg/day COM aqueous extracts and 5mg/kg/day aspirin, orally for 14 days were compared to untreated controls in mice on bleeding and clotting times, using the tail cutting and glass slide methods and for death rates in collagen-epinephrine pulmonary thrombosis, thrombolysis in vitro and euglobulin lysis time (ELT). In rats, common carotid artery FeCl3-induced thrombus and inferior vena cava thrombosis occlusion time, plasma concentrations of thromboxane B2 (TXB2) and 6-keto-prostaglandine F1α (6-keto-PGF1α) were measured.
RESULTS AND CONCLUSION:
Compared to controls, COM extracts dose-dependently prolonged bleeding by 2.17, 2.78 and 3.63 times, vs. aspirin 2.58, and the clotting time by 1.44, 2.47 and 2.48 times, vs. aspirin 1.91. COM reduced pulmonary embolus mortality by 27, 40 and 53%, vs. 47% for aspirin. COM dose-dependently increased thrombolysis by 45, 55 and 63%, vs. 56% for aspirin, and shortened ELT to 71, 61 and 43%, vs. 43% for aspirin. In rats, venous occlusion time was prolonged. Arterial and venous thrombus weights were dose-dependently reduced in COM groups. TXB2 decreased and 6-keto-PGF1α increased with COM and aspirin, with an association between 6-keto-PGF1α/TXB2 and arterial or venous thrombus weight for all products, and for occlusion time with COM but not for aspirin.
CONCLUSION:
We confirm the experimental effects of COM on hemostasis and thrombosis. Further exploration of putative clinical effects appear justified.
AuthorsWenting Zhou, Adil Abdurahman, Anwar Umar, Guldiyar Iskander, Elzira Abdusalam, Benedicte Berké, Bernard Bégaud, Nicholas Moore
JournalJournal of ethnopharmacology (J Ethnopharmacol) Vol. 154 Issue 1 Pg. 163-9 (May 28 2014) ISSN: 1872-7573 [Electronic] Ireland
PMID24704668 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 Elsevier Ireland Ltd. All rights reserved.
Chemical References
  • Cardiovascular Agents
  • Chlorides
  • Ferric Compounds
  • Plant Extracts
  • Thromboxane B2
  • 6-Ketoprostaglandin F1 alpha
  • Collagen
  • ferric chloride
  • Epinephrine
Topics
  • 6-Ketoprostaglandin F1 alpha (blood)
  • Animals
  • Blood Coagulation (drug effects)
  • Cardiovascular Agents (pharmacology, therapeutic use)
  • Carotid Artery Thrombosis (chemically induced, drug therapy)
  • Chlorides
  • Collagen
  • Epinephrine
  • Ferric Compounds
  • Fibrinolysis (drug effects)
  • Hemostasis (drug effects)
  • Male
  • Mice, Inbred ICR
  • Phytotherapy
  • Plant Extracts (pharmacology, therapeutic use)
  • Plant Leaves
  • Pulmonary Embolism (chemically induced, drug therapy)
  • Rats, Wistar
  • Rosaceae
  • Thromboxane B2 (blood)
  • Vena Cava, Inferior
  • Venous Thrombosis (chemically induced, drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: